VB Spine Acquires Stryker's Cestas Manufacturing Facility

Boston Scientific Acquires Valencia Technologies

January 12, 2026

Medical Devices

Boston Scientific acquired Valencia Technologies to advance its urology and pelvic health portfolio, adding Valencia’s implantable tibial nerve stimulation technology. The deal is expected to close in the first half of 2026, with financial terms undisclosed.

VB Spine Acquires Stryker’s Spinal Implants Business in Australia and New Zealand

July 31, 2025

Medical Devices

VB Spine LLC has completed the acquisition of Stryker’s spinal implants business in Australia and New Zealand. The deal marks VB Spine’s first market entry outside the United States; LifeHealthcare will remain the exclusive distributor across both countries, and Viscogliosi Brothers LLC and Viscogliosi Brothers Watermark LLC are equity investors in VB Spine.

Viscogliosi Brothers Acquires Stryker's U.S. Spine Business to Create VB Spine

April 1, 2025

Medical Devices

Viscogliosi Brothers, a New York–based family office, completed the acquisition of Stryker's U.S. spine business and will operate it as VB Spine, LLC. Financial partners Barings and Texas Capital Bank supported the transaction; VB Spine aims to grow the business, expand globally and retain access to Stryker technologies such as Mako Spine and Copilot.

Stryker Acquires Vertos Medical Inc.

August 22, 2024

Medical Devices

Stryker has entered into a definitive agreement to acquire Vertos Medical Inc., a privately held company that develops the minimally invasive Mild® procedure for treating lumbar spinal stenosis. The acquisition expands Stryker’s interventional pain management and minimally invasive treatment portfolio and extends its reach into ambulatory surgery centers; the transaction remains subject to customary closing conditions.

Nevro Corp. Acquires Vyrsa Technologies

November 30, 2023

Medical Devices

Nevro Corp. acquired Vyrsa Technologies, a privately held medical technology company focused on minimally invasive sacroiliac (SI) joint fusion devices, in a deal that closed November 30, 2023. Nevro paid $40 million at closing and may pay up to an additional $35 million in cash or stock tied to development and sales milestones; the company said Vyrsa will broaden its product portfolio and is projected to be accretive in 2024.

Stryker Acquires Cerus Endovascular

May 2, 2023

Medical Devices

Stryker has completed the acquisition of Cerus Endovascular Ltd., a privately held, commercial-stage medical device company that developed the Contour Neurovascular System and Neqstent devices for treatment of intracranial aneurysms. The deal expands Stryker’s Neurovascular portfolio and strengthens its aneurysm/hemorrhagic treatment capabilities globally (reported purchase price approximately $530 million).